WIRED
Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work
Potential Sciences, a startup backed by the UK government, is betting that training AI models on computer-generated biochemical data can speed up the plodding process of developing new drugs.
By WIRED
Excerpt shared by Lazyfounder
·Excerpt
Potential Sciences plans to build large-scale chemical datasets by using basic principles of physics to simulate interactions between atoms, then small molecules, then complex amino acids and proteins. With that data, it’s betting it can train AI models and prediction systems capable of identifying highly targeted drugs for specific diseases, bypassing…
Courtesy
This story was originally published by WIRED. All rights belong to the original publisher.
Read the original on wired.com ↗